Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Growth In Germany And Italy Prompts PharmaSGP To Raise Guidance

PharmaSGP has added an additional €5m to the top-end of its sales guidance after recording a double-digit gain Italy and outpacing the growth of the OTC market in Germany.

EU Follows UK In Rejecting Creatine Cognitive Health Claim

European Food Safety Authority finds no link between creatine supplementation and improved cognitive function.

People On The Move: Appointments At GSCF, MENAP-SCI, Clasado

A round-up of the latest consumer health industry appointments: GSCF names next director general, MENAP-SCI elects chairman; Clasado hires BD director.

OTC Marketing Awards 2024: What The Judges Said About The Leading Entries

The trophies have been presented at the OTC Marketing Awards 2024 - but what did the judging panel have to say about the winning and highly-commended entries?

Opella Crowned Company Of The Year At OTC Marketing Awards 2024

Winners across 12 categories were announced at the OTC Marketing Awards 2024 on 21 November, with Opella taking the top prize as OTC Company of the Year.

Norway Reverse-Switches Fluconazole Over Adverse Pregnancy Outcomes

OTC antifungal fluconazole will soon only be available with a doctor's prescription in Norway.